drugset / Trial / NCT01758640

Safety And Efficacy of Low Dose Oral Anticoagulants And Aspirin Therapy

NCT01758640

Phase 3 Completed 200 enrolled Yasser Elnahas
RandomizedParallel-groupOpen-labelPrevention

Summary

A prospective, randomized, longitudinal, open label, parallel group clinical trial was designed to compare the proportions of failure to reach INR target 2.5-3.5 with either: small dose warfarin (\<5 mg/day) or phenindione (\<100 mg/day), in high-risk pregnant and non-pregnant patients with bileaflet mechanical heart valve prosthesis.

Timeline

Start
2010-02
Primary completion
2012-06
Completion
2012-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Phenindione Small molecule 100 mg
Comparator Warfarin Small molecule 5 mg

Indications

No indication recorded.